160P Oral DNA vaccination targeting personalised neoantigens in immune checkpoint-inhibitor treated solid tumor patients: Interim results von Vaitiekus, D., Juozaityte, E., Puzauskienė, L., Tulyte, S., Gatijatullin, L., Platten, M., Poschke, I., Hulsmeyer, I., Kuhn, A., Aranguren, A., Lubenau, H., Fontenelle, H., Simovski, B., Yamashita, Y., Chaput, C., Meiser, A., Urbonas, V.

Volltext